Anixa Biosciences, Inc. ("Anixa" or the "Company") (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer today announced that it, along with its partner Moffitt ...

The guideline authors used data from 61 studies to provide recommendations on the use of neoadjuvant chemotherapy in patients with newly diagnosed, stage III-IV epithelial ovarian, fallopian tube, or ...

Anixa Biosciences receives approval of protocol amendment for ovarian cancer CAR-T clinical trial: San Jose, California Friday, February 21, 2025, 18:00 Hrs [IST] Anixa Bioscience ...

At just 31 years old, Cameron Gourley had just gotten married when she noticed a lump during her typical self-exam.

Previously, Anixa and Moffitt had secured a single patient IND approval for an additional dose for a patient whose biopsy showed ... advance the treatment of ovarian cancer with CAR-T therapy.

Amendment expands the potential benefits of CAR-T therapy allowing a second dose and includes more ovarian cancer histologies SAN JOSE, Calif., Feb. 18, 2025 /PRNewswire/ ...

Previously, Anixa and Moffitt had secured a single patient IND approval for an additional dose for a patient whose biopsy showed cellular infiltration and necrosis ... “This amendment is a crucial ...

ASCO Guidelines follow the ASCO Conflict of Interest Policy for Clinical Practice Guidelines. To provide updated guidance regarding neoadjuvant chemotherapy (NACT) and primary cytoreductive surgery ...

During the Feb. 11 event, Chris Evert and Martina Navratilova discussed memorable tournaments, double dates and their ...

Stage 3 ovarian cancer has spread outside the pelvis into the abdominal cavity or to lymph nodes. Treatment includes surgery and chemotherapy. Stage 3A1 means the cancer has spread to the lymph nodes ...

3, 72 Previous breast biopsy (whether positive or negative ... 73,74 Sporadic Ask about family history of breast/ovarian cancer in both maternal and paternal sides. Use Gail-NCI if first- or ...